New insights and therapies for teenage psoriasis

Current Opinion in Pediatrics

Volumn 20, Issue 4, 2008, Pages 419-424

  Belazarian, Leah ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Adolescent; Pediatric; Psoriasis; Teenage

Indexed keywords

ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN INHIBITOR; CALCIPOTRIOL; CEPHALOSPORIN; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOSPORIN; DAPSONE; DITHRANOL; ETANERCEPT; ETRETIN; GROWTH HORMONE; INTERLEUKIN 12; INTERLEUKIN 23; ISOTRETINOIN; KERATOLYTIC AGENT; LEUKOCYTE ANTIGEN; LUXIQ; METHOTREXATE; PENICILLIN G; PIMECROLIMUS; PSORALEN; RETINOID; SALICYLIC ACID; STEROID; TACROLIMUS; TAZAROTENE; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTIINFECTIVE AGENT; CALCINEURIN; DERMATOLOGICAL AGENT; DRUG DERIVATIVE; GLUCOCORTICOID; HLA C ANTIGEN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; VITAMIN; VITAMIN D;

ANAMNESIS; ANOREXIA; ATOPIC DERMATITIS; CARDIOVASCULAR RISK; CHEILITIS; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; CROHN DISEASE; CYTOPENIA; DEHYDRATION; DEPRESSION; DISEASE EXACERBATION; DRUG WITHDRAWAL; ELECTROLYTE DISTURBANCE; GASTROENTERITIS; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GINGIVA HYPERPLASIA; HAIR LOSS; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRICHOSIS; IMMUNOPATHOGENESIS; JUVENILE RHEUMATOID ARTHRITIS; LIVER TOXICITY; METABOLIC SYNDROME X; MONOTHERAPY; NAUSEA; NEPHROTOXICITY; OVARY CYST; PNEUMONIA; PRIORITY JOURNAL; PROTEIN FUNCTION; PRURITUS; PSORIASIS; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; PUSTULAR PSORIASIS; REVIEW; RISK FACTOR; SIDE EFFECT; SKIN COLOR; SKIN IRRITATION; STOMATITIS; TREATMENT INDICATION; TREMOR; ULTRAVIOLET B RADIATION; VOMITING; XEROSIS; ADOLESCENT; DRUG ANTAGONISM; EPIDEMIOLOGY; GENETICS; INTRADERMAL DRUG ADMINISTRATION; PHOTOTHERAPY;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ANTI-BACTERIAL AGENTS; CALCINEURIN; CAUSALITY; COMORBIDITY; DERMATOLOGIC AGENTS; GLUCOCORTICOIDS; HLA-C ANTIGENS; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-12; INTERLEUKIN-23; METHOTREXATE; PHOTOTHERAPY; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; RETINOIDS; VITAMIN D; VITAMINS;

EID: 52449119310     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e328305e24b     Document Type: Review

References (36)

1. Benoit S, Hamm H. Childhood psoriasis. Clin Dermatol 2007; 25:555-562.
2. Marcoux D, Prost Y. Pediatric psoriasis revisited. J Cutan Med Surg 2002; 6:22-28.
3. Elder JT, Nair RP, Henseler T, et al. The genetics of psoriasis 2001: the odyssey continues. Arch Dermatol 2001; 137:1447-1454.
4. Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic diseases. Br J Dermatol 2006; 155:145-151.
5. FanX, Xiao FL, Yang S, et al. Childhood psoriasis: a study of 277 patients from China. J Eur Acad Dermatol Venereol 2007; 21:762-765.
6. Seyhan M, Coskun BK, Saglam H, et al. Psoriasis in children and adolescence: evaluation of demographic and clinical features. PediatrInt 2006; 48:525-530.
7. Valdimarsson H. The genetic basis of psoriasis. Clin Dermatol 2007; 25:563-567.
8. Torti DC, Feldman SR. Interleukin-12, interleukin-23, and psoriasis: current prospects. J Am Acad Dermatol 2007; 57:1059-1068.
9. KruegerGG, Langley RG, Leonardi C, etal.A human interleukin-12/23 mono-clonal antibody for the treatment of psoriasis. N Engl J Med 2007; 356:580-592.
10. Nair RP, Ruether A, Stuart PE, et al. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol 2008 [Epub ahead of rint].
11. Kalayciyan A, Aydemir E, Kotogyan A. Experimental Koebner phenomenon in patients with psoriasis. Dermatology 2007; 215:114-117.
12. Fry L, Baker B. Triggering psoriasis: the role of infections and medications. Clin Dermatol 2007; 25:606-615.
13. Pirgon O, AtabekME, Sert A. Psoriasis following growth hormone therapy in a child. Ann Pharmacother 2007; 41:157 - 160.
14. Grinblat B, Scheinberg M. The enigmatic development of psoriasis and psoriasiform lesions during anti-TNF therapy: a review. Semin Arthritis Rheum 2008; 37:251 -255.
15. Pouessel G, Ythier H, Carpentier O, et al. Childhood pustular psoriasis associated with Panton-Valentine leukocidin-producing Staphylococcus aureus. Pediatr Dermatol 2007; 24:401 -404.
16. Morris A, Rogers M, Fischer G, Williams K. Childhood psoriasis: a clinical review of 1262 cases. Pediatr Dermatol 2001; 18:188-198.
17. Jiaravuthisan MM, Sasseville D, Vender RB, et al. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 2007; 57:1 -27.
18. Lewkowicz D, Gottlieb AB. Pediatric psoriasis and psoriatic arthritis. Dermatol Ther 2004; 17:364-375.
19. KremersHM, McEvoy M, Dann FJ, Gabriel SE. Heart disease in psoriasis. J Am Acad Dermatol 2007; 57:347-354.
20. Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296:1735-1741.
21. Christophers E. Comorbidities in psoriasis. Clin Dermatol 2007; 25:529-534.
22. Segaert S, Duvold LB. Calcipotriol cream: a review of its uses in the management of psoriasis. J Dermatol Treat 2006; 17:327-337.
23. Oranje AP, Marcoux D, Svensson A, et al. Topical calcipotriol in childhood psoriasis. J Am Acad Dermatol 1997; 36:203-208.
24. Duweb G, Alhadder J, Abuhamida M. Calcipotriol solution in scalp psoriasis. Int J Tissue React 2005; 27:163-166.
25. Brune A, Miller DW, Lin P, et al. Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients. Pediatr Dermatol 2007; 24:76-80.
26. Rogers M. Childhood psoriasis. Curr Opin Pediatr 2002; 14:404-409.
27. Pasic A, Ceovic R, Lipozencic J, et al. Phototherapy in pediatric patients. Pediatr Dermatol 2003; 20:71 -77.
28. Jury CS, McHenry P, Burden AD, et al. Narrowband ultraviolet B (UVB) phototherapy in children. Clin Dermatol 2006; 31:196-199.
29. Jain VK, Aggarwal K, Jain K, Bansal A. Narrow-band UV-B phototherapy in childhood psoriasis. Int J Dermatol 2007; 46:320-322.
30. Dadlani C, OrlowS. Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature. J Am Acad Dermatol 2005; 52:316-340.
31. Pereira TM, Vieira AP, Fernandes JC, Sousa-Basto A. Cyclosporin. A treatment in severe childhood psoriasis. J Eur Acad Dermatol Venereol 2006; 20:651 -656.
32. Hawrot AC, Metry DW, Theos AJ, Levy ML. Etanercept for psoriasis in the pediatric population: experience in nine patients. Pediatr Dermatol 2006; 23:67-71.
33. Papoutsaki M, Costanzo A, Mazzotta A, et al. Etanercept for the treatment of severe childhood psoriasis. Br J Dermatol 2006; 154:177-204.
34. Kress DW. Etanercept therapy improves symptoms and allows tapering of other medications in children and adolescents with moderate to severe psoriasis. J Am Acad Dermatol 2006; 54:S126-S128.
35. Paller AS, Siegfried EC, Langley RG, et al. Etanercept treatment for children and adolescents with plaque psoriasis. N Engl J Med 2008; 358:241-251.
36. Lebwohl M, Bagel J, Gelfand J, et al. From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis. J Am Acad Dermatol 2008; 58:94-105.